$9M Shaved From Novartis Jaw Injury Award By NY Judge

Law360, New York (October 11, 2013, 6:37 PM EDT) -- A New York judge on Wednesday denied Novartis Pharmaceuticals Corp.’s bid for a mistrial declaration in litigation over jaw deterioration injuries purportedly linked to bone drug Zometa, but slashed a $10 million punitive damage award to just less than $1 million.

U.S. District Court Judge Arthur Spatt rejected Novartis's argument that a juror had improperly relied on external information in reaching the damage award in a November 2012 plaintiff's verdict by consulting the dictionary for a definition of the word “wanton,” saying those allegations are based on...
To view the full article, register now.